Tech Company Inital Public Offerings
PPD IPO
Operating out of Wilmington, PPD completed its IPO.
Transaction Overview
Company Name
Announced On
2/6/2020
Transaction Type
IPO
Amount
$1,620,000,000
Proceeds Purpose
Use of proceeds for the PPD IPO are outlined in the company's S1 filing.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
929 N Front St.
Wilmington, NC 28401
USA
Wilmington, NC 28401
USA
Phone
Website
Email Address
Overview
PPD is a leading global contract research organization (CRO) providing discovery, development and post-approval services as well as compound partnering programs. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Simmons
Chief Financial Officer
Christopher Scully
Chief Medical Officer
Robert Dow
Chief Operating Officer
William Sharbaugh
Vice President
Anna Long
Vice President
Diem Nguyen
Vice President
Roger Smith
VP - Bus. Development
Bhooshi de Silva
VP - General Counsel
Judd Hartman
VP - General Counsel
Julia James
VP - Human Resources
Ronald Garrow
Browse more venture capital transactions:
Prev: 2/6/2020: BRAVO SIERRA venture capital transaction
Next: 2/6/2020: Aiven venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs